Literature DB >> 21537430

Molecular mechanisms of insulin resistance in type 2 diabetes mellitus.

Vandana Saini1.   

Abstract

Free fatty acids are known to play a key role in promoting loss of insulin sensitivity in type 2 diabetes mellitus but the underlying mechanism is still unclear. It has been postulated that an increase in the intracellular concentration of fatty acid metabolites activates a serine kinase cascade, which leads to defects in insulin signaling downstream to the insulin receptor. In addition, the complex network of adipokines released from adipose tissue modulates the response of tissues to insulin. Among the many molecules involved in the intracellular processing of the signal provided by insulin, the insulin receptor substrate-2, the protein kinase B and the forkhead transcription factor Foxo 1a are of particular interest, as recent data has provided strong evidence that dysfunction of these proteins results in insulin resistance in vivo. Recently, studies have revealed that phosphoinositidedependent kinase 1-independent phosphorylation of protein kinase Cε causes a reduction in insulin receptor gene expression. Additionally, it has been suggested that mitochondrial dysfunction triggers activation of several serine kinases, and weakens insulin signal transduction. Thus, in this review, the current developments in understanding the pathophysiological processes of insulin resistance in type 2 diabetes have been summarized. In addition, this study provides potential new targets for the treatment and prevention of type 2 diabetes.

Entities:  

Keywords:  Adipokines; Forkhead box protein O; Insulin receptor; Insulin receptor substrate proteins; Insulin resistance; Insulin signaling; Phosphatidylinositol 3-kinase; Protein kinase B; Type 2 diabetes mellitus

Year:  2010        PMID: 21537430      PMCID: PMC3083885          DOI: 10.4239/wjd.v1.i3.68

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  85 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  H N Ginsberg
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes.

Authors:  K Egawa; N Nakashima; P M Sharma; H Maegawa; Y Nagai; A Kashiwagi; R Kikkawa; J M Olefsky
Journal:  Endocrinology       Date:  2000-06       Impact factor: 4.736

Review 4.  Mitochondrial respiratory-chain diseases.

Authors:  Salvatore DiMauro; Eric A Schon
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

5.  Identification of cis- and trans-acting factors regulating the expression of the human insulin receptor gene.

Authors:  J K Lee; J W Tam; M J Tsai; S Y Tsai
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

6.  Impact of mutations at different serine residues on the tyrosine kinase activity of the insulin receptor.

Authors:  V Strack; B Stoyanov; B Bossenmaier; L Mosthaf; M Kellerer; H U Häring
Journal:  Biochem Biophys Res Commun       Date:  1997-10-09       Impact factor: 3.575

Review 7.  Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.

Authors:  Katsutaro Morino; Kitt Falk Petersen; Gerald I Shulman
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

8.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.

Authors:  E Araki; M A Lipes; M E Patti; J C Brüning; B Haag; R S Johnson; C R Kahn
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

9.  Protein kinase C-zeta-induced phosphorylation of Ser318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1.

Authors:  Klaus Moeschel; Alexander Beck; Cora Weigert; Reiner Lammers; Hubert Kalbacher; Wolfgang Voelter; Erwin D Schleicher; Hans-Ulrich Häring; Rainer Lehmann
Journal:  J Biol Chem       Date:  2004-04-05       Impact factor: 5.157

10.  Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y).

Authors:  A Brunetti; G Manfioletti; E Chiefari; I D Goldfine; D Foti
Journal:  FASEB J       Date:  2001-02       Impact factor: 5.191

View more
  60 in total

Review 1.  The prelude on novel receptor and ligand targets involved in the treatment of diabetes mellitus.

Authors:  Venu Gopal Jonnalagadda; Allam Venkata Sita Ram Raju; Srinivas Pittala; Afsar Shaik; Nilakash Annaji Selkar
Journal:  Adv Pharm Bull       Date:  2014-02-07

2.  INSR gene polymorphisms correlate with sensitivity to platinum-based chemotherapy and prognosis in patients with epithelial ovarian cancer.

Authors:  J-L Hu; X-L Hu; Q Han; A-Y Guo; C-J Wang; Y-Y Wen; S-D Cang
Journal:  Gene Ther       Date:  2017-04-24       Impact factor: 5.250

3.  Leucine signaling in the pathogenesis of type 2 diabetes and obesity.

Authors:  Bodo C Melnik
Journal:  World J Diabetes       Date:  2012-03-15

4.  Consumption of a drink containing extruded sorghum reduces glycaemic response of the subsequent meal.

Authors:  Pamella Cristine Anunciação; Leandro de Morais Cardoso; Valéria Aparecida Vieira Queiroz; Cicero Beserra de Menezes; Carlos Wanderlei Piler de Carvalho; Helena Maria Pinheiro-Sant'Ana; Rita de Cássia Gonçalves Alfenas
Journal:  Eur J Nutr       Date:  2016-10-12       Impact factor: 5.614

Review 5.  Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal.

Authors:  Rajat Sandhir; Smriti Gupta
Journal:  World J Diabetes       Date:  2015-09-25

6.  Protective effects of arachidonic acid against palmitic acid-mediated lipotoxicity in HIT-T15 cells.

Authors:  Young Sik Cho; Chi Hyun Kim; Ki Young Kim; Hyae Gyeong Cheon
Journal:  Mol Cell Biochem       Date:  2011-12-28       Impact factor: 3.396

Review 7.  Therapeutic potential of mesenchymal stem cells in treating both types of diabetes mellitus and associated diseases.

Authors:  Vidul Goenka; Tanhai Borkar; Aska Desai; Raunak Kumar Das
Journal:  J Diabetes Metab Disord       Date:  2020-10-17

Review 8.  Overlapped metabolic and therapeutic links between Alzheimer and diabetes.

Authors:  Waqar Ahmad
Journal:  Mol Neurobiol       Date:  2012-09-26       Impact factor: 5.590

9.  Protein Kinases Signaling in Pancreatic Beta-cells Death and Type 2 Diabetes.

Authors:  Ayse Basak Engin; Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Metformin downregulates miR223 expression in insulin-resistant 3T3L1 cells and human diabetic adipose tissue.

Authors:  Yousof Naghiaee; Reza Didehdar; Fatemeh Pourrajab; Masoud Rahmanian; Naeime Heiranizadeh; Azra Mohiti; Javad Mohiti-Ardakani
Journal:  Endocrine       Date:  2020-09-24       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.